Thackray Helen M. insider trades
Thackray Helen M. has filed 20 Form 4s with the SEC that we hold, for Biocryst Pharmaceuticals INC (BCRX) (Chief R&D Officer) and IMGN (Director). Across all of them we count 1 purchase worth $175.8K and 3 sales worth $215.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 30,000 shares of Biocryst Pharmaceuticals INC worth $175.8K, dated 2024-05-14. The first filing on our record is dated 2021-09-23 and the latest 2025-04-02.
Biocryst Pharmaceuticals INC (BCRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-04-01 | S, sale reported on Form 4 | 7,600 | $123.1K | 2022-04-04 |
| 2022-12-15 | S, sale reported on Form 4 | 3,125 | $34.0K | 2022-12-19 |
| 2023-04-03 | S, sale reported on Form 4 | 7,000 | $58.0K | 2023-04-05 |
| 2024-05-14 | P, purchase reported on Form 4 | 30,000 | $175.8K | 2024-05-15 |
IMGN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1589725) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms